Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2012
Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77.
Journal: Clinical lung cancer
Published: May 30, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026